Bioreplaceable Suture Anchors aid Shoulder Stabilization

A proprietary manufacturing process known as micro-particle dispersion (MPD) technology is used to make the BR material a homogeneous blend of PLGA and TCP particles. Dispersion of the composite particles is critical to the material strength properties. The material has shown marked absorption and a proliferation of bone cells after 18 months, with near total absorption in about 24 months. BR was developed by DePuy Mitek (Raynham, MA, USA), a Johnson and Johnson (New Brunswick, NJ, USA) company.

"Using Biocryl Rapide material in suture anchors is a natural progression in arthroscopic implant design,” said Mark H. Getelman, M.D., co-director of the sports medicine fellowship at Southern California Orthopedic Institute (SCOI; Van Nuys, CA, USA). "Since it combines an improved absorption profile with osteoconductive properties while maintaining all the strength characteristics seen with the widely used PLA implants, it may prove to be very beneficial clinically.”


Related Links:
DePuy Mitek
Johnson and Johnson